Edwards Lifesciences
1,228 hedge funds and large institutions have $37.2B invested in Edwards Lifesciences in 2024 Q4 according to their latest regulatory filings, with 192 funds opening new positions, 353 increasing their positions, 500 reducing their positions, and 140 closing their positions.
124% more call options, than puts
Call options by funds: $591M | Put options by funds: $264M
67% more funds holding in top 10
Funds holding in top 10: 6 → 10 (+4)
37% more first-time investments, than exits
New positions opened: 192 | Existing positions closed: 140
17% more capital invested
Capital invested by funds: $31.9B → $37.2B (+$5.32B)
5.2% more ownership
Funds ownership: 80.05% → 85.24% (+5.2%)
3% more funds holding
Funds holding: 1,194 → 1,228 (+34)
29% less repeat investments, than reductions
Existing positions increased: 353 | Existing positions reduced: 500
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$526M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$520M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$458M |
| 4 |
JP Morgan Chase
New York
|
+$447M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$245M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Sands Capital Management
Arlington,
Virginia
|
-$372M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$346M |
| 3 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$161M |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$140M |
| 5 |
CIM
CCLA Investment Management
London,
United Kingdom
|
-$133M |
EW Hedge Fund Activity: Q4 2024 in Review
1,228 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q4 2024, worth a combined $37.2B — up 17% from $31.9B a quarter earlier.
Buyers outnumbered sellers: 192 funds opened new EW positions and 140 closed out — a net gain of 52 holders — while 353 added to existing stakes and 500 trimmed.
The largest buyer was Jennison Associates, opening a new position worth an estimated $526M. The largest seller was Sands Capital Management, cutting an estimated $372M.
- 1,228 institutional investors held Edwards Lifesciences (EW) as of Q4 2024, up from 1,194 in Q3 2024.
- Funds reported $37.2B of Edwards Lifesciences stock for Q4 2024, up 17% quarter-over-quarter.
- 192 funds opened new Edwards Lifesciences positions in Q4 2024 and 140 closed out, a net change of +52 holders.
- The largest Edwards Lifesciences buyer in Q4 2024 was Jennison Associates, an estimated $526M added.
- The largest Edwards Lifesciences seller in Q4 2024 was Sands Capital Management, an estimated $372M sold.
Based on aggregated 13F filings for Q4 2024.